Cost effectiveness of intraperitoneal compared with intravenous chemotherapy for women with optimally resected stage III ovarian cancer: A gynecologic oncology group study
Laura J. Havrilesky, Angeles Alvarez Secord, Kathleen M. Darcy, Deborah K. Armstrong, Shalini Kulasingam
Dive into the research topics of 'Cost effectiveness of intraperitoneal compared with intravenous chemotherapy for women with optimally resected stage III ovarian cancer: A gynecologic oncology group study'. Together they form a unique fingerprint.